These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 27837105)

  • 41. Enhanced T-cell activation and T-cell-dependent IL-2 production by CD83+, CD25high, CD43high human monocyte-derived dendritic cells.
    Velten FW; Rambow F; Metharom P; Goerdt S
    Mol Immunol; 2007 Mar; 44(7):1544-50. PubMed ID: 17023048
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cutting edge: CD83 regulates the development of cellular immunity.
    Scholler N; Hayden-Ledbetter M; Dahlin A; Hellström I; Hellström KE; Ledbetter JA
    J Immunol; 2002 Mar; 168(6):2599-602. PubMed ID: 11884422
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tilting the Balance: Therapeutic Prospects of CD83 as a Checkpoint Molecule Controlling Resolution of Inflammation.
    Peckert-Maier K; Royzman D; Langguth P; Marosan A; Strack A; Sadeghi Shermeh A; Steinkasserer A; Zinser E; Wild AB
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054916
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential expression of SAP and EAT-2-binding leukocyte cell-surface molecules CD84, CD150 (SLAM), CD229 (Ly9) and CD244 (2B4).
    Romero X; Benítez D; March S; Vilella R; Miralpeix M; Engel P
    Tissue Antigens; 2004 Aug; 64(2):132-44. PubMed ID: 15245368
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human CD83-targeted chimeric antigen receptor T cells prevent and treat graft-versus-host disease.
    Shrestha B; Walton K; Reff J; Sagatys EM; Tu N; Boucher J; Li G; Ghafoor T; Felices M; Miller JS; Pidala J; Blazar BR; Anasetti C; Betts BC; Davila ML
    J Clin Invest; 2020 Sep; 130(9):4652-4662. PubMed ID: 32437331
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dendritic cell CD83: a therapeutic target or innocent bystander?
    Prazma CM; Tedder TF
    Immunol Lett; 2008 Jan; 115(1):1-8. PubMed ID: 18001846
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epithelial cell-derived CD83 restores immune tolerance in the airway mucosa by inducing regulatory T-cell differentiation.
    Mo LH; Luo XQ; Yang G; Liu JQ; Yang LT; Liu ZQ; Wang S; Liu DB; Liu ZG; Yang PC
    Immunology; 2021 Jul; 163(3):310-322. PubMed ID: 33539546
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of CD83 in the immunomodulation of dendritic cells.
    Lechmann M; Zinser E; Golka A; Steinkasserer A
    Int Arch Allergy Immunol; 2002 Oct; 129(2):113-8. PubMed ID: 12403928
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A limited course of soluble CD83 delays acute cellular rejection of MHC-mismatched mouse skin allografts.
    Xu JF; Huang BJ; Yin H; Xiong P; Feng W; Xu Y; Fang M; Zheng F; Wang CY; Gong FL
    Transpl Int; 2007 Mar; 20(3):266-76. PubMed ID: 17291220
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulatory T cells, dendritic cells and neutrophils in patients with renal cell carcinoma.
    Minárik I; Lašťovička J; Budinský V; Kayserová J; Spíšek R; Jarolím L; Fialová A; Babjuk M; Bartůňková J
    Immunol Lett; 2013 May; 152(2):144-50. PubMed ID: 23721909
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The expression and characterization of functionally active soluble CD83 by Pichia pastoris using high-density fermentation.
    Guo Y; Li R; Song X; Zhong Y; Wang C; Jia H; Wu L; Wang D; Fang F; Ma J; Kang W; Sun J; Tian Z; Xiao W
    PLoS One; 2014; 9(2):e89264. PubMed ID: 24586642
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dendritic cell CD83 homotypic interactions regulate inflammation and promote mucosal homeostasis.
    Bates JM; Flanagan K; Mo L; Ota N; Ding J; Ho S; Liu S; Roose-Girma M; Warming S; Diehl L
    Mucosal Immunol; 2015 Mar; 8(2):414-28. PubMed ID: 25204675
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells.
    Lechmann M; Krooshoop DJ; Dudziak D; Kremmer E; Kuhnt C; Figdor CG; Schuler G; Steinkasserer A
    J Exp Med; 2001 Dec; 194(12):1813-21. PubMed ID: 11748282
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of CD83 in the pathogenesis of immune thrombocytopenia.
    Wang X; Zhou Q; Yang W; Bi H; Wang H; Wang Y; Du Y; Liu L; Liu Y; Yin L; Yao J; Yu J; Tao W; Zhou Y; Zhou Z
    Hematology; 2024 Dec; 29(1):2372482. PubMed ID: 38994874
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Topical application of soluble CD83 induces IDO-mediated immune modulation, increases Foxp3+ T cells, and prolongs allogeneic corneal graft survival.
    Bock F; Rössner S; Onderka J; Lechmann M; Pallotta MT; Fallarino F; Boon L; Nicolette C; DeBenedette MA; Tcherepanova IY; Grohmann U; Steinkasserer A; Cursiefen C; Zinser E
    J Immunol; 2013 Aug; 191(4):1965-75. PubMed ID: 23851696
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Soluble CD14 and CD83 from human neonatal antigen-presenting cells are inducible by commensal bacteria and suppress allergen-induced human neonatal Th2 differentiation.
    Lundell AC; Andersson K; Josefsson E; Steinkasserer A; Rudin A
    Infect Immun; 2007 Aug; 75(8):4097-104. PubMed ID: 17526743
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Post-transcriptional regulation of CD83 expression by AUF1 proteins.
    Ehlers C; Schirmer S; Kehlenbach RH; Hauber J; Chemnitz J
    Nucleic Acids Res; 2013 Jan; 41(1):206-19. PubMed ID: 23161671
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nonspreading Rift Valley Fever Virus Infection of Human Dendritic Cells Results in Downregulation of CD83 and Full Maturation of Bystander Cells.
    Oreshkova N; Wichgers Schreur PJ; Spel L; Vloet RP; Moormann RJ; Boes M; Kortekaas J
    PLoS One; 2015; 10(11):e0142670. PubMed ID: 26575844
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Continuous expression of CD83 on activated human CD4⁺ T cells is correlated with their differentiation into induced regulatory T cells.
    Chen L; Guan S; Zhou Q; Sheng S; Zhong F; Wang Q
    Mol Med Rep; 2015 Sep; 12(3):3309-3314. PubMed ID: 25997495
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regulatory T-cell suppression of CD8+ T-cell-mediated graft-versus-host reaction requires their presence during priming.
    Wang XN; Haniffa MA; Holtick U; Collin MP; Jackson G; Hilkens CM; Holler E; Edinger M; Hoffmann P; Dickinson AM
    Transplantation; 2009 Jul; 88(2):188-97. PubMed ID: 19623013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.